Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes.
作者： S. Luzio , G. Dunseath , R. Peter , V. Pauvaday , D. R. Owens
DOI: 10.1007/S00125-006-0243-2
关键词: Diabetes mellitus 、 Insulin glargine 、 Pharmacodynamics 、 Pharmacology 、 Type 2 diabetes 、 Insulin aspart 、 Insulin 、 Glucose clamp technique 、 Biphasic Insulins 、 Medicine 、 Endocrinology 、 Internal medicine
摘要: Aims/hypothesis The pharmacokinetic and pharmacodynamic properties of biphasic insulin aspart (BIAsp 30) (30% soluble, 70% protaminated [IAsp]) glargine (IGlarg) were compared.
springer.com
core.ac.uk
swan.ac.uk
paperity.org
researchgate.net 参考文章(16)
D. R. Owens, Human Insulin: Clinical Pharmacological Studies in Normal Man ,(1986)
Robert C Turner, Carole A Cull, Valeria Frighi, Rury R Holman, UK Prospective Diabetes Study (UKPDS) Group, UK Prospective Diabetes Study (UKPDS) Group, None, Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49) JAMA. ,vol. 281, pp. 2005- 2012 ,(1999) , 10.1001/JAMA.281.21.2005
John E. Gerich, Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia Archives of Internal Medicine. ,vol. 163, pp. 1306- 1316 ,(2003) , 10.1001/ARCHINTE.163.11.1306
David M. Nathan, Initial Management of Glycemia in Type 2 Diabetes Mellitus New England Journal of Medicine. ,vol. 347, pp. 1342- 1349 ,(2002) , 10.1056/NEJMCP021106
Thomas A. Buchanan, Pancreatic beta-cell loss and preservation in type 2 diabetes. Clinical Therapeutics. ,vol. 25, ,(2003) , 10.1016/S0149-2918(03)80241-2
K. Hermansen, M. Colombo, H. Storgaard, A. Ostergaard, K. Kolendorf, S. Madsbad, Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 Diabetes Diabetes Care. ,vol. 25, pp. 883- 888 ,(2002) , 10.2337/DIACARE.25.5.883
P. Kurtzhals, L. Schaffer, A. Sorensen, C. Kristensen, I. Jonassen, C. Schmid, T. Trub, Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. ,vol. 49, pp. 999- 1005 ,(2000) , 10.2337/DIABETES.49.6.999
P. Raskin, E. Allen, P. Hollander, A. Lewin, R. A. Gabbay, P. Hu, B. Bode, A. Garber, , Initiating Insulin Therapy in Type 2 Diabetes: A comparison of biphasic and basal insulin analogs Diabetes Care. ,vol. 28, pp. 260- 265 ,(2005) , 10.2337/DIACARE.28.2.260
H. U. Janka, G. Plewe, M. C. Riddle, C. Kliebe-Frisch, M. A. Schweitzer, H. Yki-Jarvinen, Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care. ,vol. 28, pp. 254- 259 ,(2005) , 10.2337/DIACARE.28.2.254
Matthew C Riddle, Julio Rosenstock, John Gerich, Insulin Glargine 4002 Study Investigators, The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care. ,vol. 26, pp. 3080- 3086 ,(2003) , 10.2337/DIACARE.26.11.3080